CPD Events

Global Solid Tumor Summit

25 Apr 2023

About the event

Actionable biomarkers have significant implications for precision medicine. However; knowledge around the importance of biomarker testing and profiling remains an issue. The Global Solid Tumor Summit is an educational event aiming to enhance knowledge of established and emerging clinically relevant biomarkers and biomarker testing; to improve patient management. We will provide updates on current and new frontiers in biomarker testing and profiling using established (qPCR and NGS) and advanced (dPCR) technologies. The importance of biomarker testing will be highlighted throughout the sessions. This meeting will be insightful for pathologists; clinicians and laboratory scientists working with clinical diagnostics in solid tumors.

CPD Provider

QIAGEN

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QIAGEN

QIAGEN

As the innovative market and technology leader QIAGEN creates sample and assay technologies that enable access to content from any biological sample.

Want to learn more?